2,431,220 Equity Shares of Walpar Nutritions Limited are subject to a Lock-Up Agreement Ending on 31-JUL-2022.
July 31, 2022
Share
2,431,220 Equity Shares of Walpar Nutritions Limited are subject to a Lock-Up Agreement Ending on 31-JUL-2022. These Equity Shares will be under lockup for 384 days starting from 12-JUL-2021 to 31-JUL-2022.
Details:
Our Promoters have given written consent to include 910,000 Equity Shares subscribed and shall be locked-in for a period of three years from the date of commencement of commercial production or date of allotment in the Initial Public Offer.
11,66,000 shares held by promoters and 12,65,220 Equity shares held by the persons other than promoters shall be locked-in for a period of one year from the date of allotment in the Initial Public Offer.
Walpar Nutritions Limited is an India-based vertically integrated herbonutraceutical products manufacturing company. The Company is engaged in manufacturing, marketing and trading of pharmaceutical, nutraceutical, herbal and ayurvedic products online and offline. It also manufactures various private label/third party brands to different companies across the country and overseas as well own brand sales. It is a manufacturer of various types of nutraceutical formulation, pharmaceutical ingredients, and pharmaceuticals formulation. It specializes in contract manufacturing, raw materials trading, and direct selling. Its portfolio consists of tablets, capsules, powder/sachets, and oral liquids. Its products include Pcos Care Forte, Procive-F, Procive-M, Proplus, BIOMID, FERROF, FTM-plus, FTW-plus, G-Flora INOSIA-F, Joint-CR, NI-1000, Ortin-5, Ova-Wom, PCOS-CARE, Refitil-F, Refitil-M, Seagut, Spinac, TRIVITA, flaxseed- Oil, Ironica-CR, Magorich, PDF, PIYO, and Ashyuka Plus.